First Manhattan’s Akebia Therapeutics AKBA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-835,900
| Closed | -$11.4M | – | 1322 |
|
|
2020
Q2 | $11.4M | Buy |
+835,900
| New | +$11.4M | 0.07% | 137 |
|
|
2020
Q1 | – | Sell |
-123,900
| Closed | -$783K | – | 1359 |
|
|
2019
Q4 | $783K | Hold |
123,900
| – | – | ﹤0.01% | 452 |
|
|
2019
Q3 | $485K | Buy |
+123,900
| New | +$485K | ﹤0.01% | 529 |
|
|
2019
Q1 | – | Sell |
-260,200
| Closed | -$1.44M | – | 1379 |
|
|
2018
Q4 | $1.44M | Sell |
260,200
-541,166
| -68% | -$2.99M | 0.01% | 382 |
|
|
2018
Q3 | $7.08M | Buy |
801,366
+236,300
| +42% | +$2.09M | 0.04% | 226 |
|
|
2018
Q2 | $5.64M | Hold |
565,066
| – | – | 0.03% | 245 |
|
|
2018
Q1 | $5.39M | Hold |
565,066
| – | – | 0.03% | 245 |
|
|
2017
Q4 | $8.4M | Sell |
565,066
-347,434
| -38% | -$5.17M | 0.05% | 211 |
|
|
2017
Q3 | $17.9M | Sell |
912,500
-276,000
| -23% | -$5.43M | 0.1% | 138 |
|
|
2017
Q2 | $17.1M | Buy |
1,188,500
+150,000
| +14% | +$2.16M | 0.1% | 140 |
|
|
2017
Q1 | $9.55M | Hold |
1,038,500
| – | – | 0.06% | 178 |
|
|
2016
Q4 | $10.8M | Sell |
1,038,500
-666,800
| -39% | -$6.94M | 0.07% | 168 |
|
|
2016
Q3 | $15.4M | Sell |
1,705,300
-159,300
| -9% | -$1.44M | 0.09% | 141 |
|
|
2016
Q2 | $13.9M | Sell |
1,864,600
-1,200
| -0.1% | -$8.98K | 0.09% | 156 |
|
|
2016
Q1 | $16.8M | Buy |
1,865,800
+1,071,996
| +135% | +$9.66M | 0.1% | 130 |
|
|
2015
Q4 | $10.3M | Buy |
793,804
+662,500
| +505% | +$8.56M | 0.06% | 168 |
|
|
2015
Q3 | $1.27M | Buy |
+131,304
| New | +$1.27M | 0.01% | 391 |
|